Panzyga (Immunoglobulin Intravenous (Human), 10%) Correct Coding and Coverage - Revised

Panzyga® (Immunoglobulin Intravenous (Human), 10%) is a sterile liquid preparation of highly purified immunoglobulin G (IgG) derived from large pools of human plasma. The FDA approved Panzyga® on August 2, 2018. Panzyga® is covered for claims with dates of service on or after August 2, 2018 when the criteria below are met.